Vigabatrin
Overview
Vigabatrin is anticonvulsant agent. Vigabatrin is analogue of GABA (gamma amino-butyric acid). GABA is an inhibitory neurotransmitter, which is thought to be deficient in epilepsy, and able to stabilise discharges from epileptic foci. Vigabatrin is used in treatment of epilepsy, especially when not controlled by other drugs.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Vigabatrin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 21.429 to 57.143 mg/kg | 39 (39.286) | 24 hourly | PO | - |
Paedriatic Dosage (20kg)
|
| 20 to 50 mg/kg | 35 (35) | 12 hourly | Oral | - |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Vigabatrin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Vigabatrin
Back to top
Previous Drug Generic - Next Drug Generic